FDA approves Riptide Aspiration System to treat Acute Ischemic Stroke ._ Medtronic.
Medtronic plc announced that the company's Neurovascular business unit received FDA clearance of the Riptide Aspiration System, adding a valuable tool to the Acute Ischemic Stroke (AIS) product portfolio.The Riptide Aspiration System is designed to retrieve thrombus (or blood clot) through the Arc Catheter and restore blood flow in patients experiencing blockage of an artery in the brain, known as an ischemic stroke.
The procedure involves inserting a catheter through an incision in the leg and up to the blocked artery allowing the physician to remove the blood clot.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.